IMP3 and neoplasm: Regardless, according to our bioinformatic analysis of TCGA-PRAD, the expression of IMP3 was decreased in three groups related to advanced PCa (HR (RFS) < 1, TP53 mutation < wild type, pT3 < pT2, and tumor > normal).